What is LOPJLB’s current signal on TRAX?

LOPJLB’s latest quantitative signal on First Tracks Biotherapeutics Inc (TRAX) is BUY. Signals are updated daily.

What market regime is TRAX in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does First Tracks Biotherapeutics Inc (TRAX) do?

First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.

Where is First Tracks Biotherapeutics Inc based / listed?

First Tracks Biotherapeutics Inc is based in US, listed on NASDAQ.

First Tracks Biotherapeutics Inc (TRAX)

Healthcare · Biotechnology · NASDAQ · US

$43.28+0.39%Close

BUY

[SCORES & PROFILE]

FUND: 12
VALUE: 5
GROWTH: 39
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-18.1%

REV YoY-

ROE-30.1%

EPS YoY-

ROA-33.6%

GROSS

NET

[VALUATION]

P/E TTM-16.39

P/E FWD-

SECTOR PE22.62

INDUSTRY PE17.13

P/B6.22

P/FCF-

EV/EBITDA-13.15

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO8.74

ND/EBITDA-

BETA3.37

First Tracks Biotherapeutics Inc (TRAX)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news